Cytometry · 1993 · 125 citations · 27 references
Immunocytochemical TechniqueLaboratory ImmunologyImmunologyBlood CellPathologyImmunophenotypingHuman Peripheral BloodStem Cell MigrationHigh‐gradient Magnetic CellImmunotherapyStem Cell BiologyStem Cell MobilizationHematologyStem CellsHealth SciencesSmall SubpopulationAutoimmunityStem Cell TherapiesCell BiologySmall SubpopulationsCd34+ CellsStem Cell ResearchMedicine
CD34+ cells, present at a frequency of 0.18 +/- 0.052% among leukocytes from peripheral blood (PB), can be rapidly and efficiently (recovery of 39.0-74.0%) enriched to a frequency of 38.6-87.1% (54.4 +/- 12.3%) by high-gradient magnetic cell separation (MACS) for immunophenotyping, characterization in colony-forming cell (CFU) assays, and further purification to homogeneity (> 98%) by multiparameter fluorescence-activated cell sorting (FACS). Enriching PB-CD34+ cells for immunophenotyping allows the detection of small subpopulations, expressing the B-cell antigens CD10, CD19, and CD20, the T-cell antigens CD45RA and CD7, and a small subpopulation expressing high levels of CD34 (1.20 +/- 0.12%), which mostly coexpress CD19 (91.9 +/- 9.05%), CD20 (64.8 +/- 14.4%), and CD38 (84.5 +/- 10.3%). All PB-CD34+ cells express elevated levels of CD71 (transferrin receptor), with a subpopulation of high expressing cells, and CD38. Some cells express CD33. MACS-enriched PB-CD34+ cells show "normal" hematopoietic colony formation in vitro. The ease and efficiency of purification of large numbers of CD34+ cells from PB by MACS is not only relevant for the characterization of migrating stem cells but also opens new possibilities for stem cell transplantation and genetic manipulation of the hematopoietic system.
27
High gradient magnetic cell separation with MACS
Stefan Miltenyi, Werner Müller, Walter Weichel et al. · Cytometry · 1990 · 1.7K citations
Handbook of experimental immunology
W. M. H. Behan · Journal of Neuroimmunology · 1987 · 609 citations
Laboratory Immunology, Experimental Immunology, Immunology +5
Antigen CD34+ marrow cells engraft lethally irradiated baboons.
Ronald Berenson, Robert G. Andrews, D Kalamasz et al. · Journal of Clinical Investigation · 1988 · 590 citations · Full text